Indraprastha Medical Corporation is enclosing herewith the Un-audited Financial Results for the quarter and half yearly ended…

What happened

In a filing with the BSE on 29 October 2026 at 04:34 PM, Indraprastha Medical Corporation (INDRAMEDCO) said that it is enclosing herewith the Un-audited Financial Results for the quarter and half yearly ended 30th September 2026, along with a copy of the Limited Review Report by the Statutory Auditors.

From the filing: "We are enclosing herewith the Un-audited Financial Results for the quarter and half yearly ended 30th September 2026, along with a copy of the Limited Review Report by the Statutory Auditors ...."

Company snapshot

Indraprastha Medical Corporation is a small-cap company, with a market value of about ₹2,918 crore.

The stock last traded at ₹318.3, against a 52-week range of ₹293.7–₹640.9 (50.3% below the high).

Before this filing the shares had moved −14.3% over the month and −13.5% over three months. Average daily turnover over the last 20 sessions was about ₹6.74 crore.

Promoters held 51.00% at the end of Q1 FY27. Foreign institutions owned 2.77% and domestic institutions 0.59%.

What history shows

BCEIE has no earlier results filing from this company on record since May 2026.

Market-wide, 9,836 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 29 October 2026: Board meeting — Financial Results.

Source

• Exchange filing (PDF)